Outcomes of a Dispersive Ophthalmic Viscosurgical Device

Area of Science:

• Ophthalmology
• Surgical Innovation
• Corneal Science

Background:

• Cataract surgery requires effective ophthalmic viscosurgical devices (OVDs) to maintain anterior chamber integrity.
• Protecting corneal endothelial cells is crucial for successful surgical outcomes and long-term vision.
• Bio-Hyalur CS is a novel OVD designed for routine cataract procedures.

Purpose of the Study:

• To evaluate the clinical outcomes of using Bio-Hyalur CS in cataract surgery.
• To assess the protective effect of Bio-Hyalur CS on corneal endothelial cells.
• To determine the safety profile of Bio-Hyalur CS during and after surgery.

Main Methods:

• Prospective study including 60 eyes of 44 patients undergoing cataract surgery with Bio-Hyalur CS.
• Evaluation of endothelial cell density and morphology at 1 and 3 months postoperatively.
• Monitoring of intraocular pressure and recording of intraoperative/postoperative complications.

Main Results:

• Mean preoperative endothelial cell density was 2383.5 cells/mm².
• Postoperative endothelial cell density showed minimal reduction at 1 and 3 months (2186.0 and 2149.7 cells/mm², respectively).
• No adverse events were reported, indicating a favorable safety profile.

Conclusions:

• Bio-Hyalur CS offers good protection for corneal endothelial cells.
• The ophthalmic viscosurgical device demonstrates a favorable safety profile in routine cataract surgery.
• Further comparative studies with other OVDs are recommended to fully establish its clinical advantages.